Sign in

CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
271041563
Phone
949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. DEF 14A Proxy Proxy Statement
  4. DEF 14A Proxy Proxy Statement
  5. DEF 14A Proxy Proxy Statement
  6. DEF 14A Proxy Proxy Statement
  7. DEF 14A Proxy Proxy Statement
  8. DEF 14A Proxy Proxy Statement
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement
  11. DEF 14A Proxy Proxy Statement
  12. DEF 14A Proxy Proxy Statement
  13. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 13 filings